Piperacillin EP Impurity B (2Na salt)

SZ目录编号:	SZ-P048026
CAS 号	NA
分子式	C23H29N5O8S : 2Na
分子量	535.6 : 2(23.0)
投资状态	Out of Stock
Rel. CAS No	2649505-14-4 (free base)

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

化学名称: (2Ξ,4S)-2-[(Ξ)-carboxy[(2R)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)-2-phenylacetamido]methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid,disodium salt (as per EP);(2R,4S)-2-{(1R)-Carboxy[2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)-2-phenylacetamido]methyl}-5,5-dimethylthiazolidine-4-carboxylic acid, disodium salt (as per USP)

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

微笑: O=C([C@@H]1NC(C(C(O)=O)NC([C@H](NC(N2C(C(N(CC)CC2)=O)=O)=O)C3=CC=CC=C3)=O)SC1(C)C)O.[2Na]

Quantification of cefepime, meropenem, piperacillin, and tazobactam in human plasma using a sensitive and robust liquid chromatography-tandem mass spectrometry method, part 2: stability evaluation
By D'cunha, Ronilda; Bach, Thanh; Young, Beth Ann; Li, Peizhi; Nalbant, Demet; Zhang, Jun; Winokur, Patricia; An, Guohua
From Antimicrobial Agents and Chemotherapy (2018), 62(9), e00861-18/1-e00861-18/9

Stability indicating RP-HPLC method for the determination of Piperacillin and Tazobactam and their related substances in bulk and pharmaceutical formulation
By Navle, Khyathi; Prasanna, B. Lakshmi; Dometti, Hema Sree; Moodu, Shankar
From World Journal of Pharmacy and Pharmaceutical Sciences (2017), 6(8), 1760-1774

Therapeutic drug monitoring of beta-lactam antibiotics - Influence of sample stability on the analysis of piperacillin, meropenem, ceftazidime and flucloxacillin by HPLC-UV
By Pinder, Nadine; Brenner, Thorsten; Swoboda, Stefanie; Weigand, Markus A.; Hoppe-Tichy, Torsten
From Journal of Pharmaceutical and Biomedical Analysis (2017), 143, 86-93

Piperacillin EP Impurity B (2Na salt) is chemically (2Ξ,4S)-2-[(Ξ)-carboxy[(2R)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)-2-phenylacetamido]methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid,disodium salt (as per EP);(2R,4S)-2-{(1R)-Carboxy[2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)-2-phenylacetamido]methyl}-5,5-dimethylthiazolidine-4-carboxylic acid, disodium salt (as per USP). Piperacillin EP Impurity B (2Na salt) is supplied with detailed characterization data compliant with regulatory guideline. Piperacillin EP Impurity B (2Na salt) can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Piperacillin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.